首页> 外文OA文献 >Simultaneous Detection and Quantification of Mitochondrial DNA Deletion(s), Depletion, and Over-Replication in Patients with Mitochondrial Disease
【2h】

Simultaneous Detection and Quantification of Mitochondrial DNA Deletion(s), Depletion, and Over-Replication in Patients with Mitochondrial Disease

机译:线粒体疾病患者线粒体DNA缺失,耗竭和过度复制的同时检测和定量。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Heterogeneous clinical expression of mitochondrial DNA (mtDNA) disorders depends on both qualitative and quantitative changes in mtDNA. We developed a sensitive and effective method that simultaneously detects mtDNA deletion(s) and quantifies total mtDNA content. The percentage of deletions and mtDNA content of 19 patients with single or multiple deletions were analyzed by real-time quantitative polymerase chain reaction (real-time qPCR) using TaqMan probes specific for mtDNA (tRNA leuUUR, ND4, ATPase8, and D-loop regions) and nuclear DNA (AIB1, β-2-microglobulin, and β-actin). The proportion of deletion mutants determined by real-time qPCR was consistent with that determined by Southern analysis. Most patients with mtDNA deletions also demonstrated compensatory mtDNA over-replication. Multiple mtDNA deletions that were not detectable by Southern analysis due to low percentage of each deletion molecule were readily detected and quantified by real-time qPCR. Furthermore, 12 patients with clinical features and abnormal biochemical/histopathological results consistent with mitochondrial respiratory chain disorders without identified mtDNA mutations had either substantially depleted or significantly over-replicated mtDNA content, supporting the diagnosis of mitochondrial disease. Our results demonstrate that both qualitative and quantitative analyses are important in molecular diagnosis of mitochondrial diseases. The presence of deletion(s) and mtDNA depletion or compensatory over-replication can be determined simultaneously by real-time qPCR.
机译:线粒体DNA(mtDNA)疾病的异质临床表达取决于mtDNA的定性和定量变化。我们开发了一种灵敏有效的方法,可同时检测mtDNA缺失并定量总mtDNA含量。使用针对mtDNA的TaqMan探针(tRNA leuUUR,ND4,ATPase8和D环区域)通过实时定量聚合酶链反应(实时qPCR)分析了19个单缺失或多缺失的患者的缺失百分比和mtDNA含量)和核DNA(AIB1,β-2-微球蛋白和β-肌动蛋白)。通过实时qPCR确定的缺失突变体的比例与通过Southern分析确定的比例一致。大多数具有mtDNA缺失的患者也表现出代偿性mtDNA过度复制。由于每个缺失分子的百分比低,无法通过Southern分析检测到的多个mtDNA缺失很容易被实时qPCR检测和定量。此外,12例具有临床特征且生化/组织病理学结果异常且符合线粒体呼吸链疾病且未发现mtDNA突变的患者,其mtDNA含量明显减少或显着过度复制,从而支持了线粒体疾病的诊断。我们的结果表明,定性和定量分析在线粒体疾病的分子诊断中都很重要。缺失和mtDNA耗尽或代偿性过度复制的存在可以通过实时qPCR同时确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号